Mexico doesn’t have enough people like Juan Pablo Senosiain, and U.S. President Donald Trump might just be the person to help change that.
Senosiain is an innovator who helped build his family’s laboratory into one of the top five retail prescription drug companies founded in Mexico, with close to 30 patents at home and 50 abroad.
Trump’s threats to quit the North American Free Trade Agreement are giving Mexico an incentive to build more businesses like Senosiain’s that create value through research and design, as it reassesses its dependence on low-wage manufacturing.
Mexico’s leaders are trying to do more to sponsor research to stimulate development of intellectual property that can help businesses develop products the world wants. The government in April said it would match 30 percent of new and expanded research and development investments in Mexico and is seeking 375 technology projects to help fund.